La Roar Life Science ApS: Financial statements 2023
CVR: 39379775
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
La Roar Life Science ApS (CVR 39379775) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -3,548 and a net result of DKK -338,968 compared with DKK -536,509 the year before. Equity in the 2023 report amounted to DKK -1,064,550. The company had 1 employee in the financial year.
- Gross Profit
- DKK -3,548
- Profit/Loss
- DKK -338,968
- Equity
- DKK -1,064,550
- Total Assets
- DKK 580,829
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -4 t. | -339 t. | -1.1 mio. | 1 |
| 2022 | - | -64 t. | -537 t. | -726 t. | 1 |
| 2021 | - | -92 t. | -349 t. | -189 t. | 1 |
| 2020 | - | -210 t. | -762 t. | -390 t. | 1 |
| 2019 | - | -143 t. | -120 t. | -98 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
La Roar Life Science ApS has published its annual report for 2022. Gross profit came to DKK -64,359, and the net result was DKK -536,509.
About La Roar Life Science ApS
La Roar Life Science ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2018. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Peter Stampe and Tine Stampe. The company is owned by Mexico City Holding ApS and P. Stampe Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 426,332 and a net result of DKK 361,151 compared with DKK 205,065 the year before. Equity in the 2025 report amounted to DKK -498,334.